CCL4L2 is a potential biomarker for differentiating central and peripheral vertigo
CCL4L2 may serve as a potential biomarker for differentiating central from peripheral vertigo. Its expression is closely associated with inflammatory pathways, making it a promising target for further investigation in vertigo diagnostics.
Authors
- Chenjuan Tao
- Yuan Li (ORCID: https://orcid.org/0000-0002-5249-3172)
- Gaofeng Wang (ORCID: https://orcid.org/0000-0001-8202-8282)
- Xia Hong (ORCID: https://orcid.org/0000-0002-5937-8628)
Institutions
- The Fourth People's Hospital (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
Publication Details
- Journal
- Frontiers in Integrative Neuroscience
- Published
- 2025-07-21
- DOI
- https://doi.org/10.3389/fnint.2025.1620845
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical and Health Research Project of Zhejiang Province